v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Expenses:    
Research and development $ 27,960 $ 23,343
General and administrative [1] 6,906 5,692
Total operating expenses 34,866 29,035
Total operating loss (34,866) (29,035)
Other income (expense):    
Interest income, including amortization and accretion income 1,190 1,594
Other income (expense) 2 (24)
Total other income 1,192 1,570
Loss before income taxes (33,674) (27,465)
Income tax provision, net (11) (18)
Net loss $ (33,685) $ (27,483)
Net loss per common share - basic $ (0.50) $ (0.55)
Net loss per common share - diluted $ (0.50) $ (0.55)
Weighted average common stock outstanding - basic 67,447,576 50,126,148
Weighted average common stock outstanding - diluted 67,447,576 50,126,148
Comprehensive loss:    
Net loss $ (33,685) $ (27,483)
Other comprehensive income (loss):    
Unrealized loss on marketable securities (78) (137)
Currency translation adjustment (27) (21)
Total other comprehensive loss (105) (158)
Total comprehensive loss $ (33,790) $ (27,641)
[1] Includes depreciation expense directly allocated to respective activities.